Company / Working Capital
BIODESIX INC Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$15.1M
FY2025
5-year range
$6.3M / $30.5M
FY2021-FY2025
Trend
-40.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 6 years, ranging from $6M in FY2023 to $54M in FY2020.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -22.5%.
Improved from $6M to $15M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -20.9%
- 5-Year CAGR
- -22.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -22.5%, indicating a declining trend.
- In FY2025, working capital decreased 40.1% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.1M | -40.1% |
| FY2024 | $25.2M | +301.6% |
| FY2023 | $6.3M | -79.4% |
| FY2022 | $30.5M | +108.1% |
| FY2021 | $14.7M | -72.9% |
| FY2020 | $54.0M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026